3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 37.90
+0.35 (0.93%)
Mar 10, 2026, 10:39 AM CST
3D Global Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 2,923 | 5,131 | 1,088 | 1,498 | 2,143 | 2,645 | Upgrade
|
| Market Cap Growth | -41.14% | 371.49% | -27.35% | -30.09% | -18.98% | - | Upgrade
|
| Enterprise Value | 2,239 | 4,797 | 915 | 1,295 | 1,901 | 2,368 | Upgrade
|
| Last Close Price | 37.55 | 66.14 | 19.00 | 26.32 | 38.77 | 47.86 | Upgrade
|
| PE Ratio | 21.99 | 55.95 | - | - | - | - | Upgrade
|
| PS Ratio | 9.00 | 19.31 | 52.74 | 109.79 | 193.46 | 199.42 | Upgrade
|
| PB Ratio | 3.23 | 5.67 | 3.71 | 4.40 | 5.50 | 5.89 | Upgrade
|
| P/TBV Ratio | 3.54 | 6.28 | 5.69 | 6.70 | 9.03 | 9.44 | Upgrade
|
| P/FCF Ratio | 32.81 | 344.12 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 29.99 | 261.08 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 6.89 | 18.05 | 44.33 | 94.89 | 171.68 | 178.57 | Upgrade
|
| EV/EBITDA Ratio | 14.70 | 45.85 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 17.64 | 54.20 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 25.13 | 321.70 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.09 | 0.04 | 0.05 | 0.06 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.57 | 0.77 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.97 | 5.69 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.75 | -0.68 | -0.53 | -0.56 | -0.54 | -0.57 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.77 | -5.92 | 3.35 | 4.07 | 4.99 | 8.41 | Upgrade
|
| Net Debt / FCF Ratio | -7.68 | -41.52 | 4.81 | 5.43 | 5.45 | 11.01 | Upgrade
|
| Asset Turnover | 0.41 | 0.39 | 0.06 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Inventory Turnover | 2.47 | 17.14 | 4.41 | 5.14 | 9.16 | 7.15 | Upgrade
|
| Quick Ratio | 10.69 | 15.75 | 6.34 | 10.41 | 15.71 | 23.46 | Upgrade
|
| Current Ratio | 11.34 | 15.93 | 6.63 | 10.71 | 16.04 | 23.64 | Upgrade
|
| Return on Equity (ROE) | 19.65% | 15.31% | -18.28% | -18.37% | -14.24% | -10.22% | Upgrade
|
| Return on Assets (ROA) | 10.08% | 8.12% | -11.30% | -10.41% | -8.57% | -6.36% | Upgrade
|
| Return on Invested Capital (ROIC) | 57.28% | 39.90% | -43.84% | -40.57% | -33.56% | -25.96% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.90% | 9.00% | -21.10% | -18.90% | -15.20% | -10.70% | Upgrade
|
| Earnings Yield | 4.58% | 1.79% | -5.33% | -4.48% | -2.79% | -1.81% | Upgrade
|
| FCF Yield | 3.05% | 0.29% | -2.98% | -2.36% | -1.81% | -0.88% | Upgrade
|
| Dividend Yield | 1.35% | 0.80% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -31.23% | -26.08% | -2.32% | -1.69% | -0.77% | -6.02% | Upgrade
|
| Total Shareholder Return | -29.87% | -25.27% | -2.32% | -1.69% | -0.77% | -6.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.